26th Annual San Diego Heart Failure Symposium
The 26th Annual San Diego Heart Failure Symposium continues in the tradition of our past programs in providing registrants an update on the latest and most exciting advances in the management of heart failure through a series of didactic lectures.
SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Pam Taub
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Pam Taub
Login to view comments.
Click here to Login
Preventing Cardiovascular Disease and Heart Failure